Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-19

FDA Approved: DEXLANSOPRAZOLE — Original Application (ENDO USA, Inc.)

View source ↗

Summary

FDA approved ENDO USA, Inc.'s original application for dexlansoprazole (DEXLANSOPRAZOLE) as a generic on ANDA 202294. The therapy is used for gastroesophageal r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)

Snippet

ORIG AP for DEXLANSOPRAZOLE (DEXLANSOPRAZOLE)